Microbion nabs $25 mln
Vancouver, British Columbia and Bozeman, Montana-based Microbion Corp, a biopharmaceutical company focused on treating antibiotic-resistant infections, has secured $25 million in funding. The investors were Quark Venture Inc and GF Securities.
6 January 2017•1 min read
